Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer
Open Access
- 7 May 1999
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 80 (7) , 1052-1057
- https://doi.org/10.1038/sj.bjc.6690462
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1997
- Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting.Journal of Clinical Oncology, 1997
- Chemotherapy in oesophageal cancerCancer Treatment Reviews, 1997
- A phase I study of bi-weekly paclitaxel/cisplatin as initial therapy for advanced ovarian cancerAnnals of Oncology, 1996
- Paclitaxel Delivered as a 3-hr Infusion with Cisplatin in Patients with Gynecologic Cancers: Unexpected Incidence of NeurotoxicityGynecologic Oncology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Neurotoxicity is not enhanced by increased dose intensities of cisplatin administrationEuropean Journal Of Cancer, 1995
- Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the EsophagusJNCI Journal of the National Cancer Institute, 1994
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990